1620 Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Buy
7,464
+230
+3% +$18.6K 0.36% 75
2026
Q1
$627K Sell
7,234
-5,197
-42% -$498K 0.42% 69
2025
Q4
$1.19M Sell
12,431
-3
-0% -$291 0.8% 27
2025
Q3
$1.18M Buy
12,434
+131
+1% +$12K 0.8% 27
2025
Q2
$1.07M Buy
12,303
+5,541
+82% +$470K 0.76% 30
2025
Q1
$608K Buy
6,762
+232
+4% +$20.8K 0.47% 62
2024
Q4
$522K Buy
6,530
+288
+5% +$24.9K 0.4% 80
2024
Q3
$562K Buy
6,242
+94
+2% +$7.91K 0.41% 75
2024
Q2
$484K Buy
6,148
+184
+3% +$15.1K 0.37% 78
2024
Q1
$520K Buy
+5,964
New +$509K 0.52% 61

Other funds holding MDT

1620 Investment Advisors's MDT Position: Q2 2026 in Review

1620 Investment Advisors increased its Medtronic (MDT) stake by 3.2% in Q2 2026, buying an estimated $18.6K and bringing the position to 7,464 shares worth $584K. The position accounts for 0.36% of the portfolio, ranked #75.

1620 Investment Advisors first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.19M in Q4 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • 1620 Investment Advisors held 7,464 shares of Medtronic worth $584K as of Q2 2026.
  • 1620 Investment Advisors bought 230 Medtronic shares in Q2 2026, an estimated $18.6K.
  • Medtronic made up 0.36% of 1620 Investment Advisors's portfolio in Q2 2026, its #75 holding.
  • 1620 Investment Advisors first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • 1620 Investment Advisors's Medtronic position peaked at $1.19M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.